SkinCancer360

Checkpoint Therapeutics Receives Approval for PD-L1 Therapy
Featured image for “Checkpoint Therapeutics Receives Approval for PD-L1 Therapy”

Checkpoint Therapeutics Receives Approval for PD-L1 Therapy

December 16, 2024
The approval of cosibelimab-ipdl provides an option for patients with cutaneous squamous cell carcinoma December 13, 2024 (Sacramento, California) The…
Featured image for “AIM at Melanoma Announces the Launch of AIM at Skin Cancer”

AIM at Melanoma Announces the Launch of AIM at Skin Cancer

January 22, 2024
New Website Dedicated to Providing Individuals with Vital Knowledge and Tools to Protect Their Skin and Lead Healthy Lives January…
[wpb_childpages]

Recent Posts

Featured image for “Regeneron Announces Approval of Cemiplimab-rwlc for Adjuvant Treatment of Cutaneous Squamous-Cell Carcinoma with a High Risk of Recurrence After Surgery and Radiation    ”
Oct. 08, 2025

Regeneron Announces Approval of Cemiplimab-rwlc for Adjuvant Treatment of Cutaneous Squamous-Cell Carcinoma with a High Risk of Recurrence After Surgery and Radiation    

Featured image for “Preparing for Your First Oncology Visit: A Complete Guide for Skin Cancer Patients”
Sep. 29, 2025

Preparing for Your First Oncology Visit: A Complete Guide for Skin Cancer Patients

Featured image for “Skin Cancer in Aging Veterans: Unique Risks & Considerations”
Sep. 05, 2025

Skin Cancer in Aging Veterans: Unique Risks & Considerations

Featured image for “The Genetics of Skin Cancer: Insights from Dr. Kenneth Tsai”
Aug. 25, 2025

The Genetics of Skin Cancer: Insights from Dr. Kenneth Tsai

Featured image for “Understanding Merkel Cell Carcinoma: What Patients and Families Should Know”
Aug. 16, 2025

Understanding Merkel Cell Carcinoma: What Patients and Families Should Know

Post Categories